Studies have shown that in comparison to rapid occlusion of a vessel, gradual occlusion produces less severe tissue ischemia due to a more effective devel opment of collateral circulation. As other studies have shown that collateral circulation can be enhanced by stimulation of the endogenous renin-angiotensin II system, it was hypothesized that this system is involved in the mechanism of protection against ischemia that ob tains during gradual vascular occlusion. To test this hy pothesis, mortality rates were evaluated in gerbils sub jected to gradual vascular occlusion by means of progres sive carotid ligation while simultaneously infused with inhibitors of the renin-angiotensin II cascade-enala prilat or saralasin. Groups of animals with either abrupt or progressive carotid ligation infused with saline served as controls. Results showed that (1) in saline-infused an-
Gradual occlusion of a vessel results in a less de leterious effect on the tissue elements of the distal territory in comparison to an abrupt occlusion. This difference is due to the presence of adaptive mech anisms that require time to be engaged and cannot be properly utilized when the occlusion is made quickly. As a result of these adaptive mechanisms, a more effective development of collateral circula tion occurs that reduces the severity of tissue isch emia. This effect can be seen not only in the arterial side of circulation, such as cerebral or coronary ar teries (Svarzbein et aI. , 1974; To moike et aI., 1981; Bache and Schwartz, 1983; Patterson et aI. , 1983) , but also in the venous side such as the portal vein imals, there was a significant decrease in the mortality rate of progressive-ligated animals when compared to abrupt-ligated animals, and (2) administration of either enalaprilat or saralasin to progressive-ligated animals re sulted in mortality rates that were indistinguishable from those of saline-infused abrupt-ligated animals. These re sults suggest that the endogenous renin-angiotensin system is indeed involved in an adaptive mechanism that occurs during progressive ligation of the carotid artery, and more specifically, that the relatively benign effect of progressive carotid ligation may be due to the action of angiotensin II to stimulate the development of collateral circulation and reduce the severity of focal brain isch emia. Key Words: Angiotensin II-Blood pressure-Ce rebral ischemia-Collateral circulation -Enalaprilat Gerbillinae -Saralasin.
(Groszmann R, personal communication). Svarz bein et aI. (1974) reported that in the gerbil, there was a substantial difference not only in the clinical outcome, but also in the extent of change in brain microcirculation that occurred between abrupt and progressive ligation of the carotid artery. Progres sive carotid ligation would permit putative compen satory mechanisms to act more efficiently to main tain blood supply to the distal parts of the brain, maintaining the viability of the sensitive cellular el ements and, therefore, lowering morbidity and mortality. In the search for components of such a compensatory mechanism, evidence suggests that the renin-angiotensin system may play a signifi cant role (Fernandez et aI. , 1982) .
When blood supply to the kidney is reduced after a vascular obstruction, circulating levels of renin and angiotensin II increase due to the stimulation of renin release and the cascade to angiotensin II (Peach, 1977) . This increase in renin release acts, among other effects and independently of the levels of blood pressure, to protect against ischemia of a vascular territory by stimulating the development of collateral circulation. Similar effects are seen when the endogenous source of renin is removed after the administration of exogenous angiotensin II (Fernandez et aI., 1982) . Recent data suggest that infused angiotensin II serves a similar function in protecting against brain ischemia. In gerbils with focal cerebral ischemia due to an abrupt unilateral carotid artery ligation, the administration of this octapeptide produced a significant dose-dependent decrease in mortality rate by restoring blood supply to the ischemic part of the brain, which was not re lated to the pressor effect of this compound (Fer nandez et aI., 1986) .
Compelling evidence indicates that endogenous renin and a complete renin-angiotensin system exist in a wide variety of locations, including the brain (Deboben et aI., 1983; Ganong, 1984) . The brain renin-angiotensin system may have a func tion similar to that seen in the kidney, namely, pro tection against ischemia by facilitation of the devel opment of collateral circulation when blood flow through a supply artery is impaired. If the renin angiotensin system plays a role in this compensa tory mechanism, then inhibition of this system under conditions of progressive carotid occlusion should minimize its beneficial effects and result in more severe neurological deficits and an increased mortality rate. To test this hypothesis, abrupt or progressive unilateral carotid ligations were per formed in gerbils, and either an angiotensin-con verting enzyme inhibitor or an angiotensin II blocker was infused during the period of gradual occlusion. The results of these experiments show that (1) progressive carotid ligation produced a sig nificantly lower mortality rate than abrupt ligation, and (2) the mortality rate of progressively ligated animals when the renin-angiotensin system was in hibited was raised to that of abruptly ligated an imals.
MATERIALS AND METHODS
Adult male gerbils (Meriones unguiculatus; Tu mble brook Farm, Inc., West Brookfield, MA, U.S.A.), weighing between 68 and 94 g, were used. They were kept in controlled-temperature rooms at 24°C, with pe riods of light and darkness of 12 h each. The animals were fed rat chow (Ralston Purina, St. Louis, MO, U.S.A.) and tap water ad libitum. Surgical procedures were performed under sodium pentobarbital anesthesia (60 mg/kg of body weight, i.p.) using clean, but not sterile, technique. Animals were placed in the supine po sition, the neck region was cleaned with ethanol 95%, and a midline incision was made exposing the superficial J Cereb Blood Flow Metab, Vol. 8, No.2, 1988 left jugular vein and right carotid artery. A polyethylene cannula, primed with the solution to be systemically in fused, was placed in the jugular vein.
Unilateral carotid ligations were performed using two different methods: abrupt and progressive. For abrupt li gations, the right carotid artery was tied with a 4-0 silk thread after a 0.2-ml bolus of saline solution was adminis tered i. v., and infusion of saline solution was started im mediately thereafter by means of syringe driven by an infusion pump (Harvard Apparatus, Millis, MA, U.S.A.). For progressive ligations, the right carotid artery was se quentially constricted at 2-h intervals to 0.23, 0.13, and 0.0 mm. This was done by applying aneurysm clips main tained at the desired opening by interposing a wire of the proper diameter between the jaws of the clip. Immedi ately before a clip with the opening of 0.23 mm was ap plied to the right carotid artery, a bolus injection of the drug to be infused was given i.v. in a volume of 0.2 ml. The infusion was started immediatly thereafter by con necting the jugular vein cannula to the infusion device. Two hours later, the clip was changed for one with an opening of 0.13 mm for an additional 2 h, at ""hich time, a complete carotid ligation was performed with a 4-0 silk thread. Care was taken to not to release the carotid ste nosis already obtained during the change of clips.
The degree of progressive vessel ligation obtained under each condition was determined as follows: First, a dissecting microscope and measuring reticle was used to determine in vivo the resting-state external diameter of the right carotid artery in nine animals (mean ± SEM, 0.55 ± 0.01 mm), the thickness of the freshly-cut vessel wall (0.05 ± 0.003 mm), and by calculation, the lumen area of the resting-state vessel (0.16 mm2). Next, by trig onometry, the lumen area under progressive ligation was calculated, assuming that the thickness of the vessel re mained constant. For the 0.23-mm clip, lumen area was 0.077 mm2; for the 0.13 mm clip, the lumen area was 0.025 mm2; and for total ligation, the lumen area was 0.00 mm2• These yield lumen areas of 48%, 16%, and 0%, re spectively, of the resting-state vessel.
Sham carotid ligations were also performed to deter mine if the drugs alone had any effect on survival. These ligations were performed by gently manipulating the right carotid artery immediately before, 2 h into, and at the end of the 4-h infusion period.
All infusions were maintained for 4 h at a rate of 0.135 mllh, during which time the wound was covered with gauze moistened with saline. A mandatory single supple mentary dose of anesthesia (15 mg/kg, i.p.) was given to each animal at 3 h after the beginning of the infusion pe riod or, if required, before this time. As the same regimen of anesthesia was given to all animals, any protective ef fects possibly attributable to barbiturates would be iden tical in each group (Corkill et aI., 1978; Lawner et aI., 1979) . At the end of the 4-h infusion period, the venous cannula was removed, the jugular vein was tied, the skin was closed, and the animals were returned to their cages to recuperate from the anesthesia. Mortality was evalu ated at 24 and 48 h after carotid ligation. Differences in mortality rates between groups were analyzed using the log-rank test (Peto et aI., 1977) .
Six groups of animals were studied: (1) Abrupt-saline: 25 animals with abrupt carotid ligation infused with sa line.
(2) Progressive-saline: 50 animals with progressive carotid ligation infused with saline. (3) Progressive-enala prilat: 25 animals with progressive carotid ligation in-fused with the angiotensin-converting enzyme inhibitor enalaprilat {N-[(S)-I-carboxy-3-phenylpropyll-L-Ala-L Pro; Merck Institute for Therapeutic Reasearch, West Point, PA, U.S.A.} After a bolus injection of 22 J.1g/kg, an infusion dose of 1 J.1g/kg/min was given, as calculated from the work of Gross et al. (1981) . (4) Progressive-sara lasin: 25 animals with progressive carotid ligation infused with the angiotensin II blocker saralasin (SarI, Alas, an giotensin II; Norwich-Eaton Pharmaceuticals, Norwich, NY, U.S.A.). After a bolus injection of 180 J.1g/kg, an in fusion dose of 10 J.1g/kg/min was given after the work of Pals et al. (1971) and Riegger et al. (1977) . (5) Ten gerbils with sham-operated carotid artery ligation given a bolus injection and infused with enalaprilat, in a manner iden tical to group 3. (6) Ten animals with sham-operated ca rotid artery ligation given a bolus injection and infused with saralasin, in a manner identical to group 4.
All the drugs were dissolved in NaCl solution (0.9% wt/vol). The number of animals in the progressive-saline group was increased over the numbers of animals in the other non-sham groups because the mortality rate in this group was expected to be relatively low (Svarzbein et aI., 1974) .
In a separate series of experiments, the effect of the infused substances on blood pressure was measured in gerbils subjected to abrupt carotid ligation. An additional femoral catheter allowed measurement of mean blood pressure via an external transducer (Statham 23dc; Statham Gould, Hato Rey, Puerto Rico, U.S.A.) and polygraph (Grass Instruments, Quincy, MA, U.S.A.), as previously described (Fernandez et aI., 1986) . At the end of the recording period, these animals were killed.
RESULTS
Neither neurological deficits nor deaths were ob served in the sham-operated carotid ligated groups treated with enalaprilat or saralasin. Mortality rates for the other groups are summarized in Fig. 1 . As previously reported (Kahn, 1972; Berry et ai., 1975) , death was always preceded by behaviorally manifested neurological deficits of varying de grees. Progressive unilateral carotid ligation over a period of 4 h produced cumulative mortality rates 48 of 6% and 20%, whereas abrupt unilateral carotid ligation produced mortality rates of 28% and 48% at 24 and 48 h, respectively, when animals were in fused with saline (the log-rank test yielded X2 = 6. 15, df = 1, P < 0. 025). When animals were in fused with inhibitors of the renin -angiotensin system, the angiotensin-converting enzyme inhib itor enalaprilat, or the angiotensin II blocker sara lasin, progressive carotid ligation resulted in cumu lative mortality rates that were markedly increased to levels indistinguishable from those of the abrupt saline groups. The log-rank test indicated a signifi cant difference in survival across all four groups (X2 = 11. 0, df = 3, P < 0. 025).
It was initially hypothesized that infusion of ena laprilat or saralasin would counteract the more be nign effect of progressive ligation and cause the mortality rates for these two groups to approach that of the abrupt-saline group. To test this hy pothesis, the results of these three groups were sep arately compared. The log-rank test indicated no detectable difference in mortality rates among abrupt-saline, progressive-enalaprilat, and progres sive-saralasin groups (X2 = 0. 55, df = 2, P > 0. 1), suggesting that the action of these drugs was as ex pected. Even though the mechanism of action of the drug and ligation procedure in each experi mental condition was different, each shared the common purpose of minimizing the effectiveness of the renin-angiotensin system, either by not al lowing sufficient time for the system to play a role (abrupt-saline group) or by actively blocking the system (progressive-enalaprilat and progressive saralasin groups). Therefore, for the final analysis, mortality rates in these three groups were com bined into a single large group with n = 75 and were compared to that of the progressive-saline group. The log-rank test indicated that the differ- ences between these two groups was significant (X2 = 10. 69, df = 1, p < 0. 005). Blood pressure results are summarized in Fig. 2 . A bolus injection of enalaprilat produced no change, but with time, continuous infusion resulted in a slight decrease in mean arterial pressure. In contrast, a bolus injection of saralasin produced a sharp rise in mean blood pressure due to the partial agonistic effect of the compound (Pals et al. , 1971; Riegger et aI. , 1977) , which rapidly declined and stabilized during infusion to a level slightly higher than the preinjection level. Although the changes in blood pressure during infusion were in opposite di rections for enalaprilat and saralasin, mortality rates for ligated animals given the two drugs were not different, giving support to an earlier suggestion that mortality rates do not seem to be related to blood pressure levels (Fernandez et al., 1986) .
DISCUSSION
The gerbil has been proven to be a useful experi mental animal for studies of cerebral ischemia Kahn, 1972; Berry et al. , 1975; Ohno et aI. , 1984;  for a long list of references, see Robinson, 1985) . It has been established that a high percentage of gerbils develop focal brain ischemia leading to stroke and eventual death following a simple abrupt unilateral carotid ligation (Kahn, 1972) . This is due to a particular anatomical configuration of the vas cular supply to the brain (Kahn, 1972; Berry et al. , 1975) . In susceptible animals, immediately after abrupt unilateral carotid ligation, there is a signifi cant and persistent reduction of flow in the ipsilat eral hemisphere that leads, after a certain period of time, to enzymatic, chemical, and morphological changes as a result of tissue ischemia (Berry et al. , 1975; Ito et aI. , 1975; Mrsulja et al. , 1979 , Crockard et aI. , 1980 . These changes correlated with the ap pearance of behavioral manifestations of progres sive neurological deficits of varying degrees, ranging from head cocking to coma, and eventually leading to death (Berry et aI. , 1975; Ohno et aI. , 1984) .
The results of the present experiments confirm the previous findings of Svarzbein et al. (1974) that survival was markedly enhanced in the gerbil if uni lateral carotid occlusion took place gradually over a period of 4 h, rather than being abruptly performed. These congruent observations imply the presence of adaptive mechanisms that are engaged only grad ually and that act more efficiently when blood flow through the carotid artery is progressively rather than abruptly brought to a halt. Using direct micro scopic observation, Svarzbein et al. (1974) narrowing of the caliber of pial vessels and a slowing and eventual cessation of blood flow, which resulted in cortical pallor. In contrast, no changes were observed in pial vessels during and after a 4-h period of progressive ligation. It appears that gradual ligation of the carotid artery over a pe riod of time as short as 4 h is of sufficient duration to produce sustained activation of mechanisms that protect against brain ischemia. The observations of Svarzbein et ai. (1974) indicate that this protection is achieved by maintaining blood flow into territory normally irrigated by the vessel, even after com plete ligation. The present data also point to the involvement of the renin-angiotensin system in the adaptive mech anism for maintaining blood flow to ischemic brain areas. Blocking the renin-angiotensin system during progressive carotid ligation appears to in hibit this adaptive mechanism, as evidenced by an increase in mortality rate to levels not different from those seen after abrupt carotid ligation. The exact mechanism of involvement of the renin-an giotensin cascade, however, is not yet known. Nei ther renin nor angiotensin I alone appears to be the active agent. The results obtained with enalaprilat, which inhibits the angiotensin-converting enzyme, thus preventing the transformation of angiotensin I to angiotensin II (Peach, 1977) , and with the angio tensin II blocker saralasin, point to angiotensin II as being the compound critical in the adaptive pro cess during progressive carotid ligation.
The means by which angiotensin II accomplishes this protective effect remains to be determined. It has been reported that angiotensin II stimulates the formation of new vessels both in vivo and in vitro (Fernandez et aI., 1985; King et aI., 1986) . How ever, the duration of infusion and the time of evalu ation in the present experiments (4 h and up to 2 days, respectively) is rather short for neovascular ization. As it was previously discussed, it seems more likely that the protection is the result of a spe cific action of angiotensin II to rapidly activate preexisting, hitherto "in reserve" collateral pathways (Fernandez et aI., 1982 (Fernandez et aI., , 1986 .
Extrarenal renin, or isorenin, is an ubiquitous substance that has been found in many organs (De boben et aI., 1983) . Intrinsic renin in the brain was identified almost simultaneously by Fisher-Ferraro et ai. (1971) and by Ganten et ai. (1971) , and a com plete renin-angiotensin system, including the pres ence of renin substrate, angiotensin I, angiotensin converting enzyme, and angiotensin II, has been demonstrated in this organ (Printz and Gregory, 1981; Ganong, 1984) . Different actions have been attributed to the presence of angiotensin II in the brain, including neurotransmission, increase in per meability, blood flow regulation, modulation of blood pressure, dipsogenesis, secretion of antidi uretic hormone, and catecholamine release (Ganong, 1984; Phillips, 1987) . Ta king into consid eration results from preceding and present experi ments, it may well be that the brain angiotensin II is also involved in maintaining an acceptable provi sion of blood in the central nervous system to pre vent the development of ischemia. It is possible that in clinical situations, such as chronic cerebral ischemia due to progressive stenosis of the internal carotid arteries or the circle of Willis (Moyamoya disease), the endogenous brain angiogenic factor recently postulated by Matsushima and Inaba (1986) may actually be angiotensin II.
Although the hypothesis that the brain renin-an giotensin system is involved in protection against ischemia is appealing, it is not known for certain whether brain or blood-borne angiotensin II is re sponsible for this effect. In the present experi mental conditions, inhibitors of the renin-angio tensin system were administered systemically, and the presence of the blood-brain barrier may limit the movements of these compounds into the brain. However, this barrier is known to be disrupted under conditions of ischemia (Ito et aI., 1976; Ra poport, 1976; Chui et aI., 1981) , and thus, the overall permeability could be increased not only to circulating angiotensin II, but also to the infused compounds (Robertson and Khairallah, 1972) . Even if the barrier is not disrupted, these com pounds could be acting on brain structures located outside the blood-brain barrier (Ganong, 1984) or, most likely, the vessels themselves. In this regard, it is of importance that angiotensin II receptors have been identified in the cerebral microvessels (Speth and Harik, 1985) , but the exact anatomical location of these receptors is not yet known. As Speth and Harik pointed out, it will be interesting to know whether these receptors are located to ward the lumen or toward the antiluminal aspect of the brain microvessels. The physical location could indicate whether blood-borne angiotensin II or the intrinsic-to-the-brain angiotensin II is involved in the present proposed mechanism.
The evidence presented here suggests that the protective mechanism that improved survival during progressive artery ligation is related to the endogenous renin-angiotensin system. This system, through the formation and action of angio tensin II, acting most likely on cerebral micro vessels, maintains blood supply within levels nec essary to preserve metabolism, structure, and func tion of the cellular elements of the brain. This effect appears to be due to an efficient development of collateral circulation to the region of the brain nor mally serviced by the gradually occluded vessel.
